Dual Bronchodilators and β-Blockade for Cardiovascular Risk in Chronic Obstructive Pulmonary Disease
JAMA Intern Med
.
2018 May 1;178(5):730-731.
doi: 10.1001/jamainternmed.2018.1442.
Authors
Ahmad Zaheen
1
,
Anju Anand
2
,
Matthew B Stanbrook
3
Affiliations
1
Department of Respirology, University of Toronto, Toronto, Ontario, Canada.
2
Division of Respirology, St Michael's Hospital, Toronto, Ontario, Canada.
3
Division of Respirology, Toronto Western Hospital, Toronto, Ontario, Canada.
PMID:
29801135
DOI:
10.1001/jamainternmed.2018.1442
No abstract available
Publication types
Comment
MeSH terms
Administration, Inhalation
Bronchodilator Agents
Cardiovascular Diseases*
Humans
Pulmonary Disease, Chronic Obstructive*
Quality Improvement
Risk Factors
Substances
Bronchodilator Agents